Searchable abstracts of presentations at key conferences in endocrinology

ea0063p483 | Calcium and Bone 2 | ECE2019

Parathyroid hormone excess due to denosumab application and concomitant parathyroid adenoma with an atypical scintigraphic pattern- a case report

Askitis Dimitrios , Karanikas Michail , Michalopoulos Nikolaos , Strataki Aphroditi , Zissimopoulos Athanasios

Introduction: Primary hyperparathyroidism comprises one of the major causes of hypercalcaemia and is mostly due to solitary parathyroid adenoma. Denosumab is a novel antiresorptive agent for osteoporosis treatment and has been associated with a compensatory increase in PTH levels during the first months after injection, a fact that may interfere in the diagnostic procedures when dealing with concomitant small parathyroid adenomas without standard scintigraphic pattern.<p c...